Two US setbacks this week in the race to the moon with China illustrate the risks of NASA’s plans to bet on a new strategy of relying heavily on private companies.
Fresh delays in the US space agency’s Artemis moon program and a propulsion issue that doomed US company Astrobotic’s recent robot moon lander illustrate the difficulties faced by the only country to have set foot on the moon, as it tightens budgets while carrying on its cosmic legacy.
The US is planning to put astronauts back on the moon in late 2026 — delayed this week from next year — while China is targeting 2030 for its crewed landings. Before humans arrive, each space power plans to first send several smaller robotic missions to examine the moon’s surface. China’s government-backed program has scored a string of firsts.
Photo: AP
Astrobotic’s lander carried seven NASA instruments that were meant to inspect the lunar surface. Although the lander cannot make it to the surface intact, three other private moon missions sponsored by NASA, including a second Astrobotic attempt, are planned for this year.
NASA is leaning heavily on other companies such as Elon Musk’s SpaceX — which it will pay for the use of its Starship HLS lunar landing spacecraft — to slash the cost of its moon missions. The last crewed moon trips were the US Apollo missions more than half a century ago, when NASA owned all the spacecraft involved.
“I think that China has a very aggressive plan,” NASA chief Bill Nelson said on Tuesday after announcing the Artemis delay. “I think they would like to land before us, because that might give them some PR coup. But the fact is, I don’t think they will.”
US startups must develop space expertise and culture that took well-funded governments decades to develop. India is also taking that approach — leaning heavily on private companies in its space exploration efforts.
“Ten thousand things have to go right” in a debut moonshot such as Astrobotic’s, said Carnegie Mellon professor Red Whittaker, who led development of a tiny four-wheeled moon rover that was aboard Peregrine. “It’s very, very common in the course of a mission that glitches are encountered.”
Astrobotic said its executives were unavailable for interviews this week, but its Peregrine mission director, Sharad Bhaskaran, told reporters last year the company’s challenges were steep.
“We have to be a commercial company. We’re trying to be competitive in this new era of commercial spaceflight. When you look at the budgets, we have to be more creative and more efficient and do things differently,” Bhaskaran said.
China’s next step in its lunar exploration program involves an automated mission this year to retrieve samples on the moon’s far side — which would be the next in a series of firsts.
In December 2013, China’s uncrewed Chang’e-3 made the world’s first lunar soft landing since 1976. In January 2019, the also uncrewed Chang’e-4 landed on the far side of the moon, also a first.
India and firms from Israel and Japan have failed in their moon attempts in recent years.
India, which succeeded last year on its second try with its Chandrayaan-3 lander and became the first nation to touch down on the moon’s south pole, sees Astrobotic’s failure as a lesson.
“This is a much-needed learning curve for private entities similar to what the government agencies of the US, Russia and India had through their first landing attempts,” said Pawan Kumar Chandana, co-founder of Skyroot Aerospace, which launched India’s first private rocket in 2022.
“It inspires our startups to take up missions of this scale in the future,” he said.
US moon lander startup Intuitive Machines is next up in the private sector’s bid to reach the moon, and has spent about US$100 million on the mission, the company’s CEO Steve Altemus told reporters last year.
“We had to build an entire lunar program, not just a lander. So it was a little more expensive,” he said.
KEEPING UP: The acquisition of a cleanroom in Taiwan would enable Micron to increase production in a market where demand continues to outpace supply, a Micron official said Micron Technology Inc has signed a letter of intent to buy a fabrication site in Taiwan from Powerchip Semiconductor Manufacturing Corp (力積電) for US$1.8 billion to expand its production of memory chips. Micron would take control of the P5 site in Miaoli County’s Tongluo Township (銅鑼) and plans to ramp up DRAM production in phases after the transaction closes in the second quarter, the company said in a statement on Saturday. The acquisition includes an existing 12 inch fab cleanroom of 27,871m2 and would further position Micron to address growing global demand for memory solutions, the company said. Micron expects the transaction to
Nvidia Corp’s GB300 platform is expected to account for 70 to 80 percent of global artificial intelligence (AI) server rack shipments this year, while adoption of its next-generation Vera Rubin 200 platform is to gradually gain momentum after the third quarter of the year, TrendForce Corp (集邦科技) said. Servers based on Nvidia’s GB300 chips entered mass production last quarter and they are expected to become the mainstay models for Taiwanese server manufacturers this year, Trendforce analyst Frank Kung (龔明德) said in an interview. This year is expected to be a breakout year for AI servers based on a variety of chips, as
Global semiconductor stocks advanced yesterday, as comments by Nvidia Corp chief executive officer Jensen Huang (黃仁勳) at Davos, Switzerland, helped reinforce investor enthusiasm for artificial intelligence (AI). Samsung Electronics Co gained as much as 5 percent to an all-time high, helping drive South Korea’s benchmark KOSPI above 5,000 for the first time. That came after the Philadelphia Semiconductor Index rose more than 3 percent to a fresh record on Wednesday, with a boost from Nvidia. The gains came amid broad risk-on trade after US President Donald Trump withdrew his threat of tariffs on some European nations over backing for Greenland. Huang further
Sweeping policy changes under US Secretary of Health and Human Services Robert F. Kennedy Jr are having a chilling effect on vaccine makers as anti-vaccine rhetoric has turned into concrete changes in inoculation schedules and recommendations, investors and executives said. The administration of US President Donald Trump has in the past year upended vaccine recommendations, with the country last month ending its longstanding guidance that all children receive inoculations against flu, hepatitis A and other diseases. The unprecedented changes have led to diminished vaccine usage, hurt the investment case for some biotechs, and created a drag that would likely dent revenues and